Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Cascades Announces Solid Results for the Third Quarter of 2018


      News provided by

      Cascades Inc.

      Nov 08, 2018, 06:30 ET

      Share this article

      Share this article


      • Strong quarterly performance driven by record containerboard results
      • Solid Containerboard fundamentals support favourable near-term outlook

      KINGSEY FALLS, QC, Nov. 8, 2018 /PRNewswire/ - Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period ended September 30, 2018.

      Q3 2018 Highlights

      • Sales of $1,172 million
        (compared to $1,179 million in Q2 2018 (-1%) and $1,103 million in Q3 2017 (+6%))
      • As reported (including specific items)
        • Operating income of $78 million
          (compared to $73 million in Q2 2018 (+7%) and $51 million in Q3 2017 (+53%))
        • OIBD1 of $139 million
          (compared to $131 million in Q2 2018 (+6%) and $104 million in Q3 2017 (+34%))
        • Net earnings per common share of $0.38
          (compared to net earnings of $0.28 in Q2 2018 and net earnings of $0.35 in Q3 2017)
      • Adjusted (excluding specific items)2
        • Operating income of $76 million
          (compared to $76 million in Q2 2018 (stable) and $53 million in Q3 2017 (+43%))
        • OIBD of $137 million
          (compared to $134 million in Q2 2018 (+2%) and $106 million in Q3 2017 (+29%))
        • Net earnings per common share of $0.40
          (compared to net earnings of $0.30 in Q2 2018 and net earnings of $0.20 in Q3 2017)
      • European Boxboard subsidiary, via equity position in Reno De Medici S.p.A., closed the acquisition of Barcelona Cartonboard on October 31, 2018
      • Net debt2 of $1,573 million as at September 30, 2018 (compared to $1,586 million as at June 30, 2018) and net debt to adjusted OIBD ratio2 at 3.2x on a pro-forma basis3

      1 OIBD = Operating income before depreciation and amortization.

      2 For further details, please refer to the "Supplemental Information on non-IFRS Measures" section.

      3 Pro-forma basis to include 2017 and 2018 business combinations on a LTM basis.


      Mr. Mario Plourde, President and Chief Executive Officer, commented: "Strong fundamentals in Containerboard Packaging were the driving factor behind our solid third quarter performance. This was reinforced by successful margin realignment in Recovery activities, which contributed to improved quarterly earnings in Specialty Products. Results in the Tissue division continued to be impacted by rising raw material and logistics costs, in addition to the capacity-driven competitive reality. While margins in this division were below expectations as a result of these factors and weather-related events, the solid quarterly sales performance highlights the underlying strength of our tissue platform, and supports the strategic investments being made to propel long-term competitive positioning. Finally, the European Boxboard segment, via our 57.8% equity position in Reno de Medici S.p.A., announced solid results in the seasonally softer third quarter that delivered a marked improvement in profitability year-over-year.

      On the strategic front, ramp-up of the new containerboard converting facility in Piscataway, NJ progressed very well, and production from the Maspeth, NY has been transferred to the new facility earlier than expected. Engineering work and project analysis continue to be advanced for the Bear Island project in Virginia, with scope and plans expected to be finalized in the first half of 2019. Reno de Medici S.p.A. announced that it had received the necessary approval from the Spanish Antitrust Authority and closed the acquisition of Barcelona Cartonboard SAU on October 31, 2018."

      Financial Summary

      Selected consolidated information








      (in millions of Canadian dollars, except amounts per common share) (unaudited)

      Q3 2018


      Q2 2018


      Q3 2017






      Sales

      1,172


      1,179


      1,103


      As Reported




      Operating income before depreciation and amortization (OIBD)1

      139


      131


      104


      Operating income

      78


      73


      51


      Net earnings

      36


      27


      33


      per common share

      $

      0.38


      $

      0.28


      $

      0.35


      Adjusted1




      Operating income before depreciation and amortization (OIBD)

      137


      134


      106


      Operating income

      76


      76


      53


      Net earnings

      38


      29


      19


      per common share

      $

      0.40


      $

      0.30


      $

      0.20


      Margin (OIBD)

      11.7

      %

      11.4

      %

      9.6

      %

      1 - Refer to the "Supplemental Information on Non-IFRS Measures" section.

      Segmented Operating Income (loss) as reported







      (in millions of Canadian dollars) (unaudited)

      Q3 2018


      Q2 2018


      Q3 2017





      Packaging Products




      Containerboard

      94


      82


      50

      Boxboard Europe

      10


      22


      5

      Specialty Products

      9


      4


      10





      Tissue Papers

      (11)


      (9)


      9





      Corporate Activities

      (24)


      (26)


      (23)

      Operating income as reported

      78


      73


      51

      Segmented adjusted OIBD1







      (in millions of Canadian dollars) (unaudited)

      Q3 2018


      Q2 2018


      Q3 2017





      Packaging Products




      Containerboard

      117


      105


      72

      Boxboard Europe

      19


      30


      14

      Specialty Products

      14


      9


      15





      Tissue Papers

      5


      7


      24





      Corporate Activities

      (18)


      (17)


      (19)

      Adjusted OIBD

      137


      134


      106

      1 - Refer to the "Supplemental Information on Non-IFRS Measures" section.

      Analysis of results for the three-month period ended September 30, 2018 (compared to the same period last year)

      Sales of $1,172 million increased by $69 million or 6% compared to the same period last year. This was driven by a 12% increase in the Tissue segment, reflecting volume improvements, a more favourable sales mix, exchange rate and higher average sales prices during the period. An 8% increase in the Containerboard Packaging division similarly benefited sales, and was driven by higher sales prices and the acquisition of Ontario converting facilities at the end of 2017. Sales generated by the European Boxboard segment were up marginally compared to the prior year, as lower shipments were offset by improvements in both pricing and sales mix, and a favourable Canadian dollar - euro exchange rate. Finally, third quarter sales in the Specialty Products division were below prior year levels, reflecting the lower sales in recovery activities following the significant decrease in year-over-year prices of brown recycle fibres.

      Third quarter operating income stood at $78 million, a notable improvement from the $51 million generated last year. This increase was driven primarily by the Containerboard Packaging segment, where strong results reflect the improved raw material pricing environment and implementation of the industry-wide US$50/st price increase. Operating income similarly benefited from improved results generated by the European Boxboard segment, reflecting lower raw material pricing and higher average selling prices. As was the case in the second quarter, the contribution from the Specialty Products division decreased slightly compared to last year as a result of the impact of lower raw material prices on recovery activities. Lastly, results in the Tissue division reflected higher raw material and transportation costs, the effects of which mitigated the benefits derived from a more favourable pricing and sales mix, and higher volumes.

      On an adjusted basis1, third quarter operating income stood at $76 million, versus $53 million in the prior year.

      The specific items, before income taxes, that impacted our third quarter 2018 operating income and/or net earnings were:

      • a $2 million unrealized gain on financial instruments (operating income and net earnings)
      • a $1 million restructuring charge related to the forthcoming closure of two sheets plants in Ontario (operating income and net earnings)
      • a $1 million gain related to a plant closed in a previous year (operating income and net earnings)
      • a $3 million foreign exchange gain on long-term debt and financial instruments (net earnings)

      For the three-month period ended September 30, 2018, the Corporation posted net earnings of $36 million, or $0.38 per common share, compared to net earnings of $33 million, or $0.35 per common share in the same period of 2017. On an adjusted basis1, the Corporation generated net earnings of $38 million in the third quarter of 2018, or $0.40 per common share, compared to net earnings of $19 million, or $0.20 per common share, in the same period of 2017.

      1 For further details, please refer to the "Supplemental Information on non-IFRS Measures" section.

      Near-Term and Strategic Outlook

      Discussing short-term expectations, Mr. Plourde commented: "We expect solid market conditions to continue to drive results in the Containerboard business within the framework of the softer seasonal demand typical of the fourth quarter. While recent announcements regarding future capacity additions have led to some concern about longer-term demand-supply balance in the containerboard market, current data suggests that the market will remain well balanced over the medium-term. Given this, the containerboard division is expected to continue to be an important contributor to our business performance over this timeframe. Turning to Tissue, capacity additions and elevated raw material costs will continue to impact the performance of this segment in the near-term. As such, we remain focused on realizing recently announced price increases, maximizing efficiency, optimizing our operational performance, and we remain committed to strategically investing in the modernization of our asset base to reinforce our market positioning.

      Strategically, we are focused on successfully carrying out our 2018 investment program, ramping up production at our recently opened containerboard converting facility, broadening our tissue sales penetration in Oregon, and completing engineering analysis for the Bear Island project in Virginia. On a broader scale, our daily operational focus and our longer-term strategic plans continue to be driven by our commitment to be meticulous with our capital allocation practices, to diligently manage our leverage, and to successfully position our asset base for long term success."

      Dividend on common shares and normal course issuer bid

      The Board of Directors of Cascades declared a quarterly dividend of $0.04 per common share to be paid on December 5, 2018, to shareholders of record at the close of business on November 21, 2018. This dividend is an "eligible dividend" as per the Income Tax Act (R.C.S. (1985), Canada). During the third quarter of 2018, Cascades purchased 488,900 common shares for cancellation at a weighted average price of $13.27.

      2018 Third Quarter Results Conference Call Details

      Management will discuss the 2018 third quarter financial results during a conference call today at 10:00 a.m. EDT. The call can be accessed by dialing 1-888-231-8191 (international dial-in 1-647-427-7450). The conference call, including the investor presentation, will be broadcast live on the Cascades website (www.cascades.com under the "Investors" section). A replay of the call will be available on the Cascades website and may also be accessed by phone until December 8, 2018 by dialing 1-855-859-2056, access code 1998599.

      Founded in 1964, Cascades produces, converts and markets packaging and tissue products that are composed mainly of recycled fibres. The Corporation employs 11,000 employees, who work in more than 90 units located in North America and Europe. With its management philosophy, half a century of experience in recycling, and continuous efforts in research and development as driving forces, Cascades continues to serve its clients with innovative products. Cascades' shares trade on the Toronto Stock Exchange, under the ticker symbol CAS. Certain statements in this release, including statements regarding future results and performance, are forward-looking statements (as such term is defined under the Private Securities Litigation Reform Act of 1995) based on current expectations. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause actual results to differ materially from those projected, including, but not limited to, the effect of general economic conditions, decreases in demand for the Corporation's products, increases in raw material costs, fluctuations in selling prices and adverse changes in general market and industry conditions and other factors listed in the Corporation's Securities and Exchange Commission filings.

      CONSOLIDATED BALANCE SHEETS





      (in millions of Canadian dollars) (unaudited)

      September 30,
      2018


      December 31,
      2017

      Assets



      Current assets



      Cash and cash equivalents

      139


      89

      Accounts receivable

      643


      608

      Current income tax assets

      19


      18

      Inventories

      528


      523

      Current portion of financial assets

      11


      9

      Assets held for sale

      —


      13


      1,340


      1,260

      Long-term assets



      Investments in associates and joint ventures

      79


      78

      Property, plant and equipment

      2,351


      2,104

      Intangible assets with finite useful life

      203


      212

      Financial assets

      19


      23

      Other assets

      63


      73

      Deferred income tax assets

      145


      149

      Goodwill and other intangible assets with indefinite useful life

      540


      528


      4,740


      4,427

      Liabilities and Equity



      Current liabilities



      Bank loans and advances

      20


      35

      Trade and other payables

      705


      683

      Current income tax liabilities

      20


      6

      Current portion of long-term debt

      44


      59

      Current portion of provisions for contingencies and charges

      7


      7

      Current portion of financial liabilities and other liabilities

      81


      101


      877


      891

      Long-term liabilities



      Long-term debt

      1,648


      1,517

      Provisions for contingencies and charges

      38


      36

      Financial liabilities

      21


      18

      Other liabilities

      195


      178

      Deferred income tax liabilities

      219


      186


      2,998


      2,826

      Equity attributable to Shareholders



      Capital stock

      490


      492

      Contributed surplus

      16


      16

      Retained earnings

      1,091


      982

      Accumulated other comprehensive loss

      (18)


      (35)


      1,579


      1,455

      Non-controlling interests

      163


      146

      Total equity

      1,742


      1,601


      4,740


      4,427

      CONSOLIDATED STATEMENTS OF EARNINGS






      For the 3-month periods ended
      September 30,


      For the 9-month periods ended
      September 30,

      (in millions of Canadian dollars, except per common share amounts and number of common shares) (unaudited)

      2018


      2017


      2018


      2017

      Sales

      1,172


      1,103


      3,449


      3,239

      Cost of sales and expenses





      Cost of sales (including depreciation and amortization of $61 million for 3-month period (2017 — $53 million) and $174 million for 9-month period (2017 — $156 million))

      1,001


      955


      2,949


      2,820

      Selling and administrative expenses

      96


      91


      301


      285

      Gain on acquisitions, disposals and others

      —


      —


      (66)


      (8)

      Impairment charges and restructuring costs

      —


      4


      —


      18

      Foreign exchange loss (gain)

      (1)


      3


      (2)


      2

      Loss (gain) on derivative financial instruments

      (2)


      (1)


      4


      (8)


      1,094


      1,052


      3,186


      3,109

      Operating income

      78


      51


      263


      130

      Financing expense

      23


      25


      66


      70

      Interest expense on employee future benefits

      1


      1


      4


      3

      Foreign exchange gain on long-term debt and financial instruments

      (3)


      (8)


      (4)


      (27)

      Fair value revaluation gain on investments

      —


      (18)


      (5)


      (315)

      Share of results of associates and joint ventures

      (3)


      (3)


      (7)


      (36)

      Earnings before income taxes

      60


      54


      209


      435

      Provision for (recovery of) income taxes

      17


      19


      57


      (24)

      Net earnings including non-controlling interests for the period

      43


      35


      152


      459

      Net earnings attributable to non-controlling interests

      7


      2


      28


      9

      Net earnings attributable to Shareholders for the period

      36


      33


      124


      450

      Net earnings per common share





      Basic

      $

      0.38


      $

      0.35


      $

      1.31


      $

      4.75

      Diluted

      $

      0.37


      $

      0.34


      $

      1.27


      $

      4.61

      Weighted average basic number of common shares outstanding


      94,469,465



      94,718,891



      94,704,999



      94,658,949

      Weighted average number of diluted common shares


      96,780,412



      97,773,147



      97,194,029



      97,609,266

      CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME






      For the 3-month periods ended
      September 30,


      For the 9-month periods ended
      September 30,

      (in millions of Canadian dollars) (unaudited)

      2018


      2017


      2018


      2017

      Net earnings including non-controlling interests for the period

      43


      35


      152


      459

      Other comprehensive income (loss)





      Items that may be reclassified subsequently to earnings





      Translation adjustments





      Change in foreign currency translation of foreign subsidiaries

      (26)


      (34)


      24


      (56)

      Change in foreign currency translation related to net investment hedging activities

      15


      30


      (15)


      45

      Cash flow hedges





      Change in fair value of foreign exchange forward contracts

      —


      1


      (1)


      1

      Change in fair value of interest rate swaps

      —


      —


      1


      —

      Change in fair value of commodity derivative financial instruments

      2


      1


      5


      (1)

      Equity investment

      —


      (19)


      —


      —

      Share of other comprehensive income of associates

      —


      —


      —


      21

      Recovery of (provision for) income taxes

      (2)


      (2)


      1


      (15)


      (11)


      (23)


      15


      (5)

      Items that are reclassified to retained earnings





      Actuarial gain on employee future benefits

      8


      8


      13


      3

      Provision for income taxes

      (2)


      (2)


      (3)


      (1)


      6


      6


      10


      2

      Other comprehensive income (loss)

      (5)


      (17)


      25


      (3)

      Comprehensive income including non-controlling interests for the period

      38


      18


      177


      456

      Comprehensive income attributable to non-controlling interests for the period

      3


      —


      28


      9

      Comprehensive income attributable to Shareholders for the period

      35


      18


      149


      447

      CONSOLIDATED STATEMENTS OF EQUITY




      For the 9-month period ended September 30, 2018

      (in millions of Canadian dollars) (unaudited)

      CAPITAL
      STOCK


      CONTRIBUTED
      SURPLUS


      RETAINED

      EARNINGS


      ACCUMULATED
      OTHER
      COMPREHENSIVE

      LOSS


      TOTAL EQUITY
      ATTRIBUTABLE TO
      SHAREHOLDERS


      NON-
      CONTROLLING
      INTERESTS


      TOTAL
      EQUITY

      Balance - Beginning of period

      492


      16


      982


      (35)


      1,455


      146


      1,601

      New IFRS adoption

      —


      —


      (2)


      2


      —


      —


      —

      Adjusted Balance - Beginning of period

      492


      16


      980


      (33)


      1,455


      146


      1,601

      Comprehensive income








      Net earnings

      —


      —


      124


      —


      124


      28


      152

      Other comprehensive income

      —


      —


      10


      15


      25


      —


      25


      —


      —


      134


      15


      149


      28


      177

      Dividends

      —


      —


      (11)


      —


      (11)


      —


      (11)

      Stock options expense

      —


      1


      —


      —


      1


      —


      1

      Issuance of common shares upon exercise of stock options

      5


      (1)


      —


      —


      4


      —


      4

      Redemption of common shares

      (7)


      —


      (12)


      —


      (19)


      —


      (19)

      Capital contribution from a non-controlling interest

      —


      —


      —


      —


      —


      1


      1

      Dividends paid to non-controlling interests

      —


      —


      —


      —


      —


      (12)


      (12)

      Balance - End of period

      490


      16


      1,091


      (18)


      1,579


      163


      1,742










      For the 9-month period ended September 30, 2017

      (in millions of Canadian dollars) (unaudited)

      CAPITAL
      STOCK


      CONTRIBUTED
      SURPLUS


      RETAINED
      EARNINGS


      ACCUMULATED
      OTHER
      COMPREHENSIVE
      LOSS


      TOTAL EQUITY
      ATTRIBUTABLE TO
      SHAREHOLDERS


      NON-
      CONTROLLING
      INTERESTS


      TOTAL
      EQUITY

      Balance - Beginning of period

      487


      16


      512


      (31)


      984


      90


      1,074

      Comprehensive income (loss)








      Net earnings

      —


      —


      450


      —


      450


      9


      459

      Other comprehensive income (loss)

      —


      —


      2


      (5)


      (3)


      —


      (3)


      —


      —


      452


      (5)


      447


      9


      456

      Business combinations

      —


      —


      —


      —


      —


      57


      57

      Dividends

      —


      —


      (11)


      —


      (11)


      —


      (11)

      Stock options expense

      —


      1


      —


      —


      1


      —


      1

      Issuance of common shares upon exercise of stock options

      2


      (1)


      —


      —


      1


      —


      1

      Partial disposal of a subsidiary to non-controlling interests

      —


      —


      (1)


      —


      (1)


      1


      —

      Dividends paid to non-controlling interests

      —


      —


      —


      —


      —


      (5)


      (5)

      Balance - End of period

      489


      16


      952


      (36)


      1,421


      152


      1,573

      CONSOLIDATED STATEMENTS OF CASH FLOWS






      For the 3-month periods ended
      September 30,


      For the 9-month periods ended
      September 30,

      (in millions of Canadian dollars) (unaudited)

      2018


      2017


      2018


      2017

      Operating activities






      Net earnings attributable to Shareholders for the period

      36


      33


      124


      450

      Adjustments for:





      Financing expense and interest expense on employee future benefits

      24


      26


      70


      73

      Depreciation and amortization

      61


      53


      174


      156

      Gain on acquisitions, disposals and others

      —


      —


      (66)


      (8)

      Impairment charges and restructuring costs

      —


      2


      —


      13

      Unrealized loss (gain) on derivative financial instruments

      (2)


      (2)


      5


      (10)

      Foreign exchange gain on long-term debt and financial instruments

      (3)


      (8)


      (4)


      (27)

      Provision for (recovery of) income taxes

      17


      19


      57


      (24)

      Fair value revaluation gain on investments

      —


      (18)


      (5)


      (315)

      Share of results of associates and joint ventures

      (3)


      (3)


      (7)


      (36)

      Net earnings attributable to non-controlling interests

      7


      2


      28


      9

      Net financing expense paid

      (39)


      (40)


      (94)


      (88)

      Net income taxes paid

      (6)


      —


      (4)


      (6)

      Dividends received

      3


      3


      4


      8

      Employee future benefits and others

      (3)


      (6)


      (10)


      (12)


      92


      61


      272


      183

      Changes in non-cash working capital components

      42


      (43)


      16


      (105)


      134


      18


      288


      78

      Investing activities





      Investments in associates and joint ventures

      —


      —


      (2)


      (16)

      Payments for property, plant and equipment

      (124)


      (38)


      (274)


      (136)

      Proceeds from disposals of property, plant and equipment

      —


      —


      82


      14

      Change in intangible and other assets

      (4)


      283


      (11)


      272

      Net cash acquired in business combinations

      —


      —


      3


      34


      (128)


      245


      (202)


      168

      Financing activities





      Bank loans and advances

      (1)


      7


      (16)


      5

      Change in revolving credit facilities

      5


      (133)


      15


      (80)

      Increase in other long-term debt

      54


      5


      65


      11

      Payments of other long-term debt

      (7)


      (10)


      (62)


      (29)

      Settlement of derivative financial instruments

      —


      (2)


      (1)


      (9)

      Issuance of common shares upon exercise of stock options

      —


      —


      4


      1

      Redemption of common shares

      (7)


      —


      (19)


      —

      Dividends paid to non-controlling interests

      (2)


      (2)


      (12)


      (5)

      Capital contribution from non-controlling interests

      —


      —


      1


      —

      Dividends paid to the Corporation's Shareholders

      (3)


      (3)


      (11)


      (11)


      39


      (138)


      (36)


      (117)

      Change in cash and cash equivalents during the period

      45


      125


      50


      129

      Currency translation on cash and cash equivalents

      (3)


      —


      —


      1

      Cash and cash equivalents - Beginning of period

      97


      67


      89


      62

      Cash and cash equivalents - End of period

      139


      192


      139


      192

      SEGMENTED INFORMATION

      The Corporation analyzes the performance of its operating segments based on their operating income before depreciation and amortization, which is not a measure of performance under International Financial Reporting Standards (IFRS); however, the chief operating decision-maker (CODM) uses this performance measure to assess the operating performance of each reportable segment. Earnings for each segment are prepared on the same basis as those of the Corporation. Intersegment operations are recorded on the same basis as sales to third parties, which are at fair market value. The accounting policies of the reportable segments are the same as the Corporation's accounting policies described in its most recent audited consolidated financial statements for the year ended December 31, 2017.

      The Corporation's operating segments are reported in a manner consistent with the internal reporting provided to the CODM. The Chief Executive Officer has authority for resource allocation and management of the Corporation's performance, and is therefore the CODM.

      The Corporation's operations are managed in four segments: Containerboard, Boxboard Europe and Specialty Products (which constitutes the Corporation's Packaging Products), and Tissue Papers.


      SALES


      For the 3-month periods ended
      September 30,


      For the 9-month periods ended
      September 30,

      (in millions of Canadian dollars) (unaudited)

      2018


      2017


      2018


      2017

      Packaging Products






      Containerboard

      472


      438


      1,368


      1,212

      Boxboard Europe

      210


      202


      688


      626

      Specialty Products

      164


      181


      487


      542

      Intersegment sales

      (21)


      (32)


      (68)


      (81)


      825


      789


      2,475


      2,299

      Tissue Papers

      361


      323


      1,008


      967

      Intersegment sales and Corporate Activities

      (14)


      (9)


      (34)


      (27)


      1,172


      1,103


      3,449


      3,239




      OPERATING INCOME (LOSS) BEFORE DEPRECIATION AND AMORTIZATION


      For the 3-month periods ended
      September 30,


      For the 9-month periods ended
      September 30,

      (in millions of Canadian dollars) (unaudited)

      2018


      2017


      2018


      2017

      Packaging Products





      Containerboard

      116


      69


      359


      165

      Boxboard Europe

      19


      14


      77


      48

      Specialty Products

      15


      15


      31


      53


      150


      98


      467


      266

      Tissue Papers

      5


      22


      25


      78

      Corporate Activities

      (16)


      (16)


      (55)


      (58)

      Operating income before depreciation and amortization

      139


      104


      437


      286

      Depreciation and amortization

      (61)


      (53)


      (174)


      (156)

      Financing expense and interest expense on employee future benefits

      (24)


      (26)


      (70)


      (73)

      Foreign exchange gain on long-term debt and financial instruments

      3


      8


      4


      27

      Fair value revaluation gain on investments

      —


      18


      5


      315

      Share of results of associates and joint ventures

      3


      3


      7


      36

      Earnings before income taxes

      60


      54


      209


      435




      PAYMENTS FOR PROPERTY, PLANT AND EQUIPMENT


      For the 3-month periods ended
      September 30,


      For the 9-month periods ended
      September 30,

      (in millions of Canadian dollars) (unaudited)

      2018


      2017


      2018


      2017

      Packaging Products





      Containerboard

      107


      13


      247


      28

      Boxboard Europe

      15


      8


      23


      20

      Specialty Products

      8


      8


      25


      17


      130


      29


      295


      65

      Tissue Papers

      29


      9


      57


      53

      Corporate Activities

      4


      3


      13


      11

      Total acquisitions

      163


      41


      365


      129

      Proceeds from disposals of property, plant and equipment

      —


      —


      (82)


      (14)

      Capital lease acquisitions and included in other debts

      (33)


      —


      (99)


      (7)


      130


      41


      184


      108

      Acquisitions for property, plant and equipment included in "Trade and other payables"





      Beginning of period

      14


      8


      28


      25

      End of period

      (20)


      (11)


      (20)


      (11)

      Payments for property, plant and equipment net of proceeds from disposals

      124


      38


      192


      122

      SUPPLEMENTAL INFORMATION ON NON-IFRS MEASURES

      SPECIFIC ITEMS

      The Corporation incurs some specific items that adversely or positively affect its operating results. We believe it is useful for readers to be aware of these items, as they provide additional information to measure performance, compare the Corporation's results between periods and assess operating results and liquidity, notwithstanding these specific items. Management believes these specific items are not necessarily reflective of the Corporation's underlying business operations in measuring and comparing its performance and analyzing future trends. Our definition of specific items may differ from those of other corporations, and some of them may arise in the future and may reduce the Corporation's available cash.

      They include, but are not limited to, charges for (reversals of) impairment of assets, restructuring gains or costs, loss on refinancing and repurchase of long-term debt, some deferred tax asset provisions or reversals, premiums paid on long-term debt refinancing, gains or losses on the acquisition or sale of a business unit, gains or losses on the share of results of associates and joint ventures, unrealized gains or losses on derivative financial instruments that do not qualify for hedge accounting, unrealized gains or losses on interest rate swaps, foreign exchange gains or losses on long-term debt, specific items of discontinued operations and other significant items of an unusual, non-cash or non-recurring nature.

      RECONCILIATION OF NON-IFRS MEASURES

      To provide more information for evaluating the Corporation's performance, the financial information included in this analysis contains certain data that are not performance measures under IFRS ("non-IFRS measures"), which are also calculated on an adjusted basis to exclude specific items. We believe that providing certain key performance measures and non-IFRS measures is useful to both management and investors as they provide additional information to measure the performance and financial position of the Corporation. It also increases the transparency and clarity of the financial information. The following non-IFRS measures are used in our financial disclosures:

      • Operating income before depreciation and amortization (OIBD): Used to assess operating performance and contribution of each segment when excluding depreciation & amortization. OIBD is widely used by investors as a measure of a corporation's ability to incur and service debt and as an evaluation metric.
      • Adjusted OIBD: Used to assess operating performance and contribution of each segment on a comparable basis.
      • Adjusted operating income: Used to assess operating performance of each segment on a comparable basis.
      • Adjusted net earnings: Used to assess the Corporation's consolidated financial performance on a comparable basis.
      • Adjusted free cash flow: Used to assess the Corporation's capacity to generate cash flows to meet financial obligation and/or discretionary items such as share repurchase, dividend increase and strategic investments.
      • Net debt to adjusted OIBD ratio: Used to measure the Corporation's credit performance and evaluate the financial leverage.
      • Net debt to adjusted OIBD ratio on a pro-forma basis: Used to measure the Corporation's credit performance and evaluate the financial leverage on a comparable basis including significant business acquisitions and excluding significant business disposals, if any.

      Non-IFRS measures are mainly derived from the consolidated financial statements but do not have meanings prescribed by IFRS. These measures have limitations as an analytical tool, and should not be considered on their own or as a substitute for an analysis of our results as reported under IFRS. In addition, our definitions of non-IFRS measures may differ from those of other corporations. Any such modification or reformulation may be significant.

      The reconciliation of operating income (loss) to OIBD, to adjusted operating income (loss) and to adjusted OIBD by business segment is as follows:


      Q3 2018

      (in millions of Canadian dollars)

      Containerboard

      Boxboard
      Europe

      Specialty
      Products

      Tissue
      Papers

      Corporate
      Activities

      Consolidated

      Operating income (loss)

      94

      10

      9

      (11)

      (24)

      78

      Depreciation and amortization

      22

      9

      6

      16

      8

      61

      Operating income (loss) before depreciation and amortization

      116

      19

      15

      5

      (16)

      139

      Specific items:







      Restructuring costs

      1

      —

      (1)

      —

      —

      —

      Unrealized gain on financial instruments

      —

      —

      —

      —

      (2)

      (2)


      1

      —

      (1)

      —

      (2)

      (2)

      Adjusted operating income (loss) before depreciation and amortization

      117

      19

      14

      5

      (18)

      137

      Adjusted operating income (loss)

      95

      10

      8

      (11)

      (26)

      76




      Q2 2018

      (in millions of Canadian dollars)

      Containerboard

      Boxboard
      Europe

      Specialty

      Products

      Tissue

      Papers

      Corporate

      Activities

      Consolidated

      Operating income (loss)

      82

      22

      4

      (9)

      (26)

      73

      Depreciation and amortization

      20

      8

      5

      16

      9

      58

      Operating income (loss) before depreciation and amortization

      102

      30

      9

      7

      (17)

      131

      Specific items :







      Unrealized loss on derivative financial instruments

      3

      —

      —

      —

      —

      3


      3

      —

      —

      —

      —

      3

      Adjusted operating income (loss) before depreciation and amortization

      105

      30

      9

      7

      (17)

      134

      Adjusted operating income (loss)

      85

      22

      4

      (9)

      (26)

      76




      Q3 2017

      (in millions of Canadian dollars)

      Containerboard

      Boxboard

      Europe

      Specialty

      Products

      Tissue
      Papers

      Corporate

      Activities

      Consolidated

      Operating income (loss)

      50

      5

      10

      9

      (23)

      51

      Depreciation and amortization

      19

      9

      5

      13

      7

      53

      Operating income (loss) before depreciation and amortization

      69

      14

      15

      22

      (16)

      104

      Specific items:







      Impairment charges

      —

      —

      —

      2

      —

      2

      Restructuring costs

      2

      —

      —

      —

      —

      2

      Unrealized loss (gain) on financial instruments

      1

      —

      —

      —

      (3)

      (2)


      3

      —

      —

      2

      (3)

      2

      Adjusted operating income (loss) before depreciation and amortization

      72

      14

      15

      24

      (19)

      106

      Adjusted operating income (loss)

      53

      5

      10

      11

      (26)

      53

      Net earnings, as per IFRS, is reconciled below with operating income, adjusted operating income and adjusted operating income before depreciation and amortization:







      (in millions of Canadian dollars) (unaudited)

      Q3 2018


      Q2 2018


      Q3 2017





      Net earnings attributable to Shareholders for the year

      36


      27


      33

      Net earnings attributable to non-controlling interests

      7


      10


      2

      Provision for income taxes

      17


      16


      19

      Fair value revaluation gain on investments

      —


      —


      (18)

      Share of results of associates and joint ventures

      (3)


      (3)


      (3)

      Foreign exchange gain on long-term debt and financial instruments

      (3)


      —


      (8)

      Financing expense and interest expense on employee future benefits

      24


      23


      26

      Operating income

      78


      73


      51

      Specific items:




      Impairment charges

      —


      —


      2

      Restructuring costs

      —


      —


      2

      Unrealized loss (gain) on derivative financial instruments

      (2)


      3


      (2)


      (2)


      3


      2

      Adjusted operating income

      76


      76


      53

      Depreciation and amortization

      61


      58


      53

      Adjusted operating income before depreciation and amortization

      137


      134


      106

      The following table reconciles net earnings and net earnings per common share, as per IFRS, with adjusted net earnings and adjusted net earnings per common share:






      NET EARNINGS


      NET EARNINGS PER SHARE 1

      (in millions of Canadian dollars, except amounts per share) (unaudited)

      Q3 2018


      Q2 2018


      Q3 2017


      Q3 2018


      Q2 2018


      Q3 2017









      As per IFRS

      36


      27


      33


      $

      0.38


      $

      0.28


      $

      0.35

      Specific items:








      Impairment charges

      —


      —


      2


      —


      —


      $

      0.02

      Restructuring costs

      —


      —


      2


      —


      —


      $

      0.01

      Unrealized loss (gain) on derivative financial instruments

      (2)


      3


      (2)


      $

      (0.02)


      $

      0.03


      $

      (0.01)

      Unrealized gain on interest rate swaps

      —


      (1)


      —


      —


      $

      (0.01)


      —

      Foreign exchange gain on long-term debt and financial instruments

      (3)


      —


      (8)


      $

      (0.02)


      —


      $

      (0.08)

      Fair value revaluation gain on investments

      —


      —


      (18)


      —


      —


      $

      (0.17)

      Tax effect on specific items, other tax adjustments and attributable to non-controlling interest1

      7


      —


      10


      $

      0.06


      —


      $

      0.08


      2


      2


      (14)


      $

      0.02


      $

      0.02


      $

      (0.15)

      Adjusted

      38


      29


      19


      $

      0.40


      $

      0.30


      $

      0.20



      1

      Specific amounts per common share are calculated on an after-tax basis and are net of the portion attributable to non-controlling interests. Per common share amounts in line item ''Tax effect on specific items, other tax adjustments and attributable to non-controlling interests'' only include the effect of tax adjustments.

      The following table reconciles cash flow from operating activities with operating income and operating income before depreciation and amortization:







      (in millions of Canadian dollars)

      Q3 2018


      Q2 2018


      Q3 2017

      Cash flow from operating activities

      134


      116


      18

      Changes in non-cash working capital components

      (42)


      (5)


      43

      Depreciation and amortization

      (61)


      (58)


      (53)

      Net income taxes paid

      6


      1


      —

      Net financing expense paid

      39


      18


      40

      Impairment charges and restructuring costs

      —


      —


      (2)

      Unrealized gain (loss) on derivative financial instruments

      2


      (3)


      2

      Dividend received, employee future benefits and others

      —


      4


      3

      Operating income

      78


      73


      51

      Depreciation and amortization

      61


      58


      53

      Operating income before depreciation and amortization

      139


      131


      104

      The following table reconciles cash flow from operating activities with cash flow from operating activities (excluding changes in non-cash working capital components) and adjusted cash flow from operating activities. It also reconciles adjusted cash flow from operating activities to adjusted free cash flow, which is also calculated on a per common share basis:







      (in millions of Canadian dollars, except amount per common share or otherwise mentioned)

      Q3 2018


      Q2 2018


      Q3 2017

      Cash flow from operating activities

      134


      116


      18

      Changes in non-cash working capital components

      (42)


      (5)


      43

      Cash flow from operating activities (excluding changes in non-cash working capital components)

      92


      111


      61

      Specific items, net of current income taxes if applicable:




      Restructuring costs

      —


      —


      2

      Adjusted cash flow from operating activities

      92


      111


      63

      Capital expenditures & other assets1 and capital lease payments

      (129)


      (72)


      (46)

      Dividends paid to the Corporation's Shareholders and to non-controlling interests

      (5)


      (12)


      (5)

      Adjusted free cash flow

      (42)


      27


      12

      Adjusted free cash flow per common share

      $

      (0.44)


      $

      0.29


      $

      0.13

      Weighted average basic number of common shares outstanding


      94,469,465



      94,638,464



      94,718,891

      1 Excluding increase in investments






      The following table reconciles total debt and net debt with the ratio of net debt to adjusted operating income before depreciation and amortization (adjusted OIBD): 







      (in millions of Canadian dollars)

      September 30,
      2018


      June 30,
      2018


      September 30,
      2017

      Long-term debt

      1,648


      1,616


      1,575

      Current portion of long-term debt

      44


      46


      53

      Bank loans and advances

      20


      21


      33

      Total debt

      1,712


      1,683


      1,661

      Less: Cash and cash equivalents (including $26 million of restricted cash in June 30, 2018)

      139


      97


      192

      Net debt

      1,573


      1,586


      1,469

      Adjusted OIBD (last twelve months)

      481


      450


      370

      Net debt / Adjusted OIBD ratio

      3.3


      3.5


      4.0

      Net debt / Adjusted OIBD ratio on a pro forma basis1

      3.2


      3.5


      3.6

      1 Pro-forma to include adjusted OIBD of 2017 and 2018 business acquisitions on a last twelve months basis.

      Follow us on social media:

      Website: www.cascades.com
      Twitter: twitter.com/CascadesInvest
      Facebook: facebook.com/Cascades
      YouTube: youtube.com/Cascades

      SOURCE Cascades Inc.

      Modal title

      Also from this source

      Cascades Announces the Retirement of Vice-President and Chief Financial Officer Allan Hogg in the Second Half of 2027

      Cascades Announces the Retirement of Vice-President and Chief Financial Officer Allan Hogg in the Second Half of 2027

      Cascades inc. (TSX: CAS), announces that its Vice-President and Chief Financial Officer, Allan Hogg, will retire in the second half of 2027,...

      Cascades Reports Third Quarter 2026 Results

      Cascades Reports Third Quarter 2026 Results

      Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period ended September 30, 2026. Q3 2026 Highlights Sales of...

      More Releases From This Source

      Explore

      Paper, Forest Products & Containers

      Paper, Forest Products & Containers

      Dividends

      Dividends

      Earnings

      Earnings

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.